Navigation Links
Ikaria(R) Names New Chairman
Date:10/19/2009

CLINTON, N.J., Oct. 19 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that Board Chairman David E. Shaw is retiring from the board. Current Ikaria CEO Daniel Tasse has been named Chairman of the Board, succeeding Shaw, who has served as Chairman since 2007.

Shaw was a founding investor and director in Ikaria, Inc., a biotechnology company that was formed in 2005, and was instrumental in combining it with INO Therapeutics in 2007 to form Ikaria Holdings, Inc. The transaction, valued at $670M, was led by New Mountain Capital and included ARCH Venture Partners and Venrock. Shaw served as founding CEO until Tasse's appointment as Director, President and CEO in January 2008. He is active in other private and public companies, and serves as Managing Partner of Black Point Group and a partner at Venrock.

"Ikaria exists and flourishes today because of the direction David Shaw established for the company from the beginning, including its focus on critical care and the formation of a strong and experienced management team," said Daniel Tasse, Chairman and CEO of Ikaria. "We thank David for his vision and leadership and wish him continued success in his future endeavors."

Prior to joining Ikaria in January 2008, Tasse served as General Manager of the $2 billion Pharmaceuticals & Technologies business of Baxter International, Inc., a division which was created by integrating the company's Anesthesia, Critical Care and BioPharma Solutions units. Prior to his tenure at Baxter International, Tasse held management positions at GlaxoSmithKline and Upjohn. He has a B.Sci. in Biochemistry from the University of Montreal.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a biotherapeutics company whose acute care products and therapies address the significant unmet needs of critically ill patients. The company's lead product, INOmax® (nitric oxide) for inhalation, is the only FDA-approved
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
2. Ikaria(R) to Present at 27th Annual JPMorgan Healthcare Conference
3. IKARIA(R) to In-License BioLineRxs BL-1040
4. KGI Names Kerry Howell Vice President for Advancement
5. Vical Names Andrew de Guttadauro Vice President, Corporate Development
6. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
7. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
8. CryoLife Names Philip Theodore as Vice President, General Counsel
9. Genstar Names Michael Hurt to Its Strategic Advisory Board
10. PPD Names Daniel Darazsdi as Chief Financial Officer
11. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Mass. , Jan. 14, 2014  RXi Pharmaceuticals ... discovering, developing and commercializing innovative therapies addressing major ... that it received the Notice of Allowance from ... its unique self-delivering RNAi compounds (sd-rxRNA®), for the ...
(Date:1/14/2014)... ®, provider of RapidResponse ®, a cloud-based supply chain ... S&OP ) service, is proud to be a gold sponsor ... at the Hilton San Diego Bayfront, January 30 – 31, ... , Director of Supply Chain at Amgen, as she presents ...
(Date:1/14/2014)... January 14, 2014 Kerr Corporation, a leading ... and additional how-to information about dual arch impressions on its ... Dual Arch Impressions,” the blog entry serves up a list ... houses a step-by-step demonstration by Dr. David Little as he ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Independent ... County), California, and Montreal, Canada, has big ideas for ... non-fiction. The press's goals are to produce high-quality, low-cost, ... to support local businesses. , The first major ...
Breaking Biology Technology:RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Bitingduck Press Looks Forward to 2014 With Multimedia E-books 2
... CHICAGO, Nov. 29, 2011 Compressus today introduced the ... workflow solutions with the release of the MEDxConnect™ System ... release features a highly flexible platform that empowers users ... market challenges. The Company made the announcement here shown ...
... Calif., Nov. 29, 2011 GeneTex, a leading ... is pleased to announce that they will be ... and Hec1. Both of these targets are key ... http://photos.prnewswire.com/prnh/20111129/LA13485-a ) (Logo:   http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b ...
... A*STAR Singapore took lead roles in a study that ... culture of human embryonic stem cells (hESCs). The study ... of the University of Sheffield (UK), Paul Robson of ... Singapore,s Bioprocessing Technology Institute (BTI), and Barbara Knowles and ...
Cached Biology Technology:Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0 2Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0 3Compressus Drives Programmable Workflow And Unprecedented Flexibility With Introduction of MEDxConnect™ v4.0 4GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly 2GeneTex Antibody Company to Launch New Line of Primary Antibodies for the Study of Spindle Assembly 3Singapore scientists lead human embryonic stem cell study 2Singapore scientists lead human embryonic stem cell study 3
(Date:4/16/2014)... legal, artisanal green sea turtle fishery has uncovered a ... in what may have become an unsustainable take, according ... University of Florida. , During the research period, conservation ... killed between 1991 and 2011, with catch rates peaking ...
(Date:4/16/2014)... Armand-Frappier has just received a research grant from the National ... The 5-year grant is to pursue cutting-edge research in the ... biomedical potential in the field of oncology as well as ... at this level is an accomplishment in itself," said Yves ...
(Date:4/16/2014)... all of our movements, thoughts and feelings are the ... have suggested that some of the conversations might not be ... listening in on, or even participating in, some of those ... only be tuning in part of the time specifically, ...
Breaking Biology News(10 mins):Declining catch rates in Caribbean green turtle fishery may be result of overfishing 2Declining catch rates in Caribbean green turtle fishery may be result of overfishing 3High-level NIH grant goes to professor Nicolas Doucet of INRS 2Eavesdropping on brain cell chatter 2Eavesdropping on brain cell chatter 3
... that voting decisions are more associated with the ... appearance than to positive ones, says a team ... (Caltech), Scripps College, Princeton University, and the University ... when voters have little or no information about ...
... male partner is on your case. In fact, he ... kept to the straight and narrow. The flip side ... be better than men at concealing illicit liaisons., Paul ... gave 203 young heterosexual couples confidential questionnaires asking them ...
... Deane Evans will provide an introduction to the basics of building ... to the public, at NJIT. The talk, set for Nov. ... of the status of the NJ schools, construction program. ... Evans, a registered architect, is executive director of NJIT,s ...
Cached Biology News:Caltech-led researchers find negative cues from appearance alone matter for real elections 2Caltech-led researchers find negative cues from appearance alone matter for real elections 3Caltech-led researchers find negative cues from appearance alone matter for real elections 4Men are better at detecting infidelities 2
... long and short-term enriched housing for nonhuman ... quarantine and non-quarantine settings on a per ... utilizing our state-of-the-art social housing and nursery ... on site CDC quarantine facilities. Primate ...
... gel stain has bright fluorescence when bound to ... ideal for detecting dsDNA in gels using laser ... I nucleic gel acid stain has also ... and bandshift assays. One mL stains 100 minigels. ...
Eagle's Ham's amino acids; EHAA...
... IRsolution software provides quick and easy operation ... with Windows-based control. The software is ... FDA 21 CFR Part 11 regulations, and ... measurement. IRsolutions versatility enables use in ...
Biology Products: